Stockholders' Equity - Summary of Company's Restricted Share Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Options Outstanding
Beginning balance (in shares)	116,000
Granted (in shares)	0
Exercised (in shares)	0	0
Canceled/forfeited (in shares)	0
Expired (in shares)	0
Ending balance (in shares)	116,000		116,000
Exercisable (in shares)	116,000
Weighted- Average Exercise Price
Weighted average exercise price, beginning balance (in dollars per share)	$ 3.07
Weighted average exercise price, granted (in dollars per share)	0
Weighted average exercise price, exercised (in dollars per share)	0
Weighted average exercise price, canceled/forfeited (in dollars per share)	0
Weighted average exercise price, expired (in dollars per share)	0
Weighted average exercise price, ending balance (in dollars per share)	3.07		$ 3.07
Weighted average exercise price, exercisable (in dollars per share)	$ 3.07
Weighted-average remaining contractual term, outstanding	3 years 7 months 6 days		3 years 10 months 24 days
Weighted-average remaining contractual term, exercisable	3 years 7 months 6 days
Aggregate intrinsic value outstanding	$ 261		$ 192
Aggregate intrinsic value exercisable	$ 261

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.